Priser
Platform
Blog
Om os
Download
Nelnet (Class A)
Nelnet (Class A)
New York Stock Exchange
0

Om

Sinphar Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical industry, renowned for its dedication to the development, manufacture, and distribution of a wide array of medicinal products. The company focuses on producing over-the-counter drugs, ethical medications, and active pharmaceutical ingredients, catering to a diverse healthcare market. Its product range extends to health supplements, adding a holistic approach to public wellness. Sinphar Pharmaceutical's operations are underpinned by robust research and development efforts, emphasizing innovation and quality in therapeutics. The company significantly contributes to the healthcare sector by enhancing treatment efficacy and safety through advanced technologies and rigorous quality controls. With a strong presence in both domestic and international markets, Sinphar Pharmaceutical Co., Ltd. plays a crucial role in meeting the growing demands for effective healthcare solutions. Its commitment to sustainable practices and continuous improvement in drug formulations makes it a vital player in the global pharmaceutical landscape.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I NELNET (CLASS A) MED ENDAVU: Køb Nelnet (Class A) ($NNI) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Nelnet (Class A), og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker1734
Land
Taiwan
Hjemmesidesinphar.com.tw
SektorSundhed
IndustriBioteknologi

Udbytter

0,17TWD
'20
0,17TWD
'21
0,17TWD
'22
0,84TWD
'23
0,91TWD
'24
0,91TWD
'25
Ex-udbytte-dato11. jul. 2025
Udbytteafkast2,99%